UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in LENZ — LENZ Therapeutics, Inc.

CIK 861177 NEW YORK, NY

Back to LENZ Full portfolio

Position in LENZ

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$812

-$235,147 QoQ

Shares Held

143

-99.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#127

of 143 holders

Holding Since

Jun 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in LENZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. LENZ ranks #198 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,086,683	$1,533,248,041
2	REGN	Regeneron Pharmaceuticals, Inc.	716,560	$446,803,817
3	ALNY	Alnylam Pharmaceuticals, Inc.	727,848	$219,104,078
4	INCY	Incyte Corp	1,508,720	$171,028,494
5	RVMD	Revolution Medicines, Inc.	912,335	$170,862,094
6	INSM	INSMED Inc	1,335,071	$142,345,265
7	IONS	Ionis Pharmaceuticals Inc	1,454,672	$115,340,938
8	MRNA	Moderna, Inc.	1,521,849	$106,575,080

All Filings in LENZ

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$812	143	-99.4%	Shares	Defined	2026-08-13
2026-03-31	$235,959	25,788	+36.8%	Shares	Defined	2026-05-13
2025-12-31	$301,616	18,851	+61.2%	Shares	Defined	2026-02-13
2025-09-30	$544,846	11,697	-53.5%	Shares	Defined	2025-11-14
2025-06-30	$737,292	25,155	—	Shares	Defined	2025-08-14
2022-03-31 GRPH	—	241,451	-5.9%	Shares	Sole	2022-05-16
2021-12-31 GRPH	—	256,726	-42.0%	Shares	Sole	2022-02-14
2021-09-30 GRPH	—	442,704	+12.4%	Shares	Defined	2021-11-15
2021-06-30 GRPH	—	393,787	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.